View Post

U.S. May Lose Measles Free Status

In COVID-19, Latest News by Precision Vaccinations

After being designated as free of measles for two decades, the United States is at risk of losing its status due to recent measles outbreaks.
Over the past fifteen months, 338 cases of measles have been reported. Among these cases, 96% were associated with importation.
Among the 326 import-associated cases, 61% occurred among U.S. residents who were eligible for vaccination but were unvaccinated or whose vaccination status was unknown.
Furthermore, in 2024 alone, seven measles outbreaks (3+ cases) have been reported in the U.S.

View Post

Philippines Deploys Pentavalent Vaccine Against Pertussis Outbreak

In COVID-19, Latest News by Precision Vaccinations

The Department of Health (DOH) in the Republic of the Philippines has taken action to address the Pertussis outbreak.
Data as of March 30, 2024, indicates that there have been 1,112 Pertussis (whooping cough) cases since the start of 2024, which is almost 34 times higher than during the same period in 2023.
The majority of these cases were found in unvaccinated children under the age of five.
On April 11, 2024, the DOH reassured the public that outbreak response immunization was underway—however, the national government's inventory is in short supply.

View Post

Real World Evidence Supports Protein-based COVID-19 Vaccination

In COVID-19, Latest News by Precision Vaccinations

In the early stages of the recent pandemic, clinical studies reported differing levels of effectiveness for COVID-19 vaccines.
One reason for this was that people's immune composition was continuously changing due to new SARS-CoV-2 variants, booster doses, and updated vaccine types.
However, one missing data component was needed to understand these innovative vaccines' effectiveness fully.
Recently, real-world evidence was published that supports the continued use of protein-based COVID-19 vaccines.

View Post

Mpox Outbreaks Have Not Ended

In COVID-19, Latest News by Precision Vaccinations

While the international community has focused on the extensive mpox outbreak in the Democratic Republic of the Congo, this sexually transmitted disease has resurfaced in the United States.
According to the U.S. Centers for Disease Control and Prevention (CDC), as of the week ending March 30, 2024 (Week #13), there were 664 mpox cases in the U.S.
New York (142), California (67), and Texas (43) are the leading states reporting mpox cases in 2024.
This data compares with just 307 reported in the same period in 2023.

View Post

Dengue Outbreaks Continue in the Caribbean

In COVID-19, Latest News by Precision Vaccinations

The Pan American Health Organization (PAHO) recently joined the U.S. CDC in issuing dengue outbreak warnings for the Region of the Americas.
As of March 26, 2024, over 3.5 million cases and more than 1,000 deaths have been reported in the Americas.
"This is cause for concern, as it represents three times more cases than those reported for the same period in 2023, a record year with more than 4.5 million cases reported in the region," PAHO Director Jarbas Barbosa said during a recent press briefing.